DOGE’s Medicaid data experiment adds a new player to healthcare fraud enforcement: the public

By releasing a sweeping Medicaid claims dataset, DOGE is testing whether broader public analysis can complement government fraud investigations. The move raises questions about accuracy, accountability and whether this approach is scalable or sustainable. I'll walk through the pros and cons with John Barry, senior counsel at Epstein Becker Green.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.